肺炎球菌结合疫苗普遍使用前后非疫苗血清型的流行病学。
Epidemiology of non-vaccine serotypes of before and after universal administration of pneumococcal conjugate vaccines.
机构信息
Key Laboratory of Major Diseases in Children, Ministry of Education, National Key Discipline of Pediatrics, Laboratory of Microbiology, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
出版信息
Hum Vaccin Immunother. 2021 Dec 2;17(12):5628-5637. doi: 10.1080/21645515.2021.1985353. Epub 2021 Nov 2.
Abstract
The universal administration of pneumococcal conjugate vaccines (PCVs) had been demonstrated as an effective way to prevent infection. However, the immunity induced by PCVs protected against the infections caused by vaccine serotypes, which were usually more frequent than non-vaccine serotypes (NVTs). The prevalence and pathogenicity of NVTs after universal vaccination have caused widespread concern. We reviewed the epidemiology of non-PCV13 e before and after PCV13 introduction, and explored the potential reasons for the spread of NVTs. Emerging and spreading NVTs can be regarded as the focus for future serotype epidemiological survey and vaccine optimization.IPD: invasive pneumococcal disease PCV: pneumococcal conjugate vaccines VT: vaccine serotypeNVT: non-vaccine serotype.
摘要
通用型肺炎球菌结合疫苗（PCV）的应用已被证实为预防感染的有效方法。然而，PCV 所诱导的免疫仅能针对疫苗血清型引起的感染提供保护，而这些血清型通常比非疫苗血清型（NVTs）更为常见。PCV 广泛应用后，NVTs 的流行率和致病性引起了广泛关注。我们对 PCV13 引入前后非-PCV13 型的流行病学进行了综述，并探讨了 NVTs 传播的潜在原因。新兴和传播的 NVTs 可被视为未来血清型流行病学调查和疫苗优化的重点。IPD：侵袭性肺炎球菌病 PCV：肺炎球菌结合疫苗 VT：疫苗血清型 NVT：非疫苗血清型
相似文献
1
Epidemiology of non-vaccine serotypes of before and after universal administration of pneumococcal conjugate vaccines.肺炎球菌结合疫苗普遍使用前后非疫苗血清型的流行病学。
Hum Vaccin Immunother. 2021 Dec 2;17(12):5628-5637. doi: 10.1080/21645515.2021.1985353. Epub 2021 Nov 2.
2
High prevalence of antimicrobial resistance in non-vaccine serotypes of non-invasive/colonization isolates of Streptococcus pneumoniae: A cross-sectional study eight years after the licensure of conjugate vaccine in Japan.肺炎链球菌非侵袭性/定植分离株非疫苗血清型的抗菌药物耐药率高：日本上市结合疫苗 8 年后的一项横断面研究。
J Infect Public Health. 2020 Aug;13(8):1094-1100. doi: 10.1016/j.jiph.2020.04.012. Epub 2020 May 21.
3
The rise and fall of pneumococcal serotypes carried in the PCV era.肺炎球菌结合疫苗（PCV）时代所携带的肺炎球菌血清型的兴衰。
Vaccine. 2017 Mar 1;35(9):1293-1298. doi: 10.1016/j.vaccine.2017.01.035. Epub 2017 Feb 1.
4
Exploring the evidence behind the comparable impact of the pneumococcal conjugate vaccines PHiD-CV and PCV13 on overall pneumococcal disease.探讨肺炎球菌结合疫苗 PHiD-CV 和 PCV13 对总体肺炎球菌疾病产生相当影响的证据。
Hum Vaccin Immunother. 2022 Dec 31;18(1):1872341. doi: 10.1080/21645515.2021.1872341. Epub 2021 Feb 19.
5
genomic datasets from an Indian population describing pre-vaccine evolutionary epidemiology using a whole genome sequencing approach.使用全基因组测序方法描述印度人群中疫苗前进化流行病学的基因组数据集。
Microb Genom. 2021 Sep;7(9). doi: 10.1099/mgen.0.000645.
6
Early Streptococcus pneumoniae serotype changes in Utah adults after the introduction of PCV13 in children.儿童接种13价肺炎球菌结合疫苗（PCV13）后犹他州成年人中早期肺炎链球菌血清型变化
Vaccine. 2016 Jan 20;34(4):474-478. doi: 10.1016/j.vaccine.2015.12.010. Epub 2015 Dec 17.
7
Spread of multidrug resistance in non-PCV13/PCV20 serotypes of Streptococcus pneumoniae: A cross-sectional study ten years after the introduction of pneumococcal conjugate vaccine in Japan.肺炎链球菌非 13 价/20 价结合疫苗血清型中多药耐药性的传播：日本引入肺炎球菌结合疫苗十年后的横断面研究。
J Microbiol Immunol Infect. 2023 Dec;56(6):1288-1292. doi: 10.1016/j.jmii.2023.07.004. Epub 2023 Jul 20.
8
Pneumococcal serotype evolution in Western Europe.西欧肺炎球菌血清型的演变。
BMC Infect Dis. 2015 Oct 14;15:419. doi: 10.1186/s12879-015-1147-x.
9
A systematic review of invasive pneumococcal disease vaccine failures and breakthrough with higher-valency pneumococcal conjugate vaccines in children.儿童高价肺炎球菌结合疫苗预防侵袭性肺炎球菌病失败和突破性疾病的系统评价
Expert Rev Vaccines. 2022 Feb;21(2):201-214. doi: 10.1080/14760584.2022.2012455. Epub 2022 Feb 3.
10
Divergent serotype replacement trends and increasing diversity in pneumococcal disease in high income settings reduce the benefit of expanding vaccine valency.在高收入环境中，肺炎球菌疾病的血清型替代趋势不同，且多样性不断增加，这降低了扩大疫苗效价的获益。
Sci Rep. 2020 Nov 4;10(1):18977. doi: 10.1038/s41598-020-75691-5.
引用本文的文献
1
Safety and efficacy of an intramuscular bivalent vaccine against influenza and Streptococcus pneumoniae infections in mice.一种用于预防小鼠流感和肺炎链球菌感染的肌肉注射二价疫苗的安全性和有效性
Med Microbiol Immunol. 2025 Aug 29;214(1):39. doi: 10.1007/s00430-025-00848-w.
2
Combating Antimicrobial Resistance: Role of Key Stakeholders with Focus on the Pharmaceutical Sector.抗击抗菌药物耐药性：关键利益相关者的作用，重点关注制药行业。
Pharmaceut Med. 2025 Jul 11. doi: 10.1007/s40290-025-00572-z.
3
Cost-effectiveness and budget impact analyses of the 24-valent pneumococcal conjugate vaccine in adults aged 50 and older.50岁及以上成年人使用24价肺炎球菌结合疫苗的成本效益和预算影响分析。
Vaccine. 2025 Aug 13;61:127433. doi: 10.1016/j.vaccine.2025.127433. Epub 2025 Jul 1.
4
Molecular detection and serotyping of acute bacterial meningitis pathogens in Indian children.印度儿童急性细菌性脑膜炎病原体的分子检测与血清分型
Eur J Clin Microbiol Infect Dis. 2025 Jun 28. doi: 10.1007/s10096-025-05198-2.
5
Peptide vaccines: an innovative therapeutic approach against antibiotic-resistant bacterial infections.肽疫苗：一种针对耐抗生素细菌感染的创新治疗方法。
Front Immunol. 2025 May 21;16:1567584. doi: 10.3389/fimmu.2025.1567584. eCollection 2025.
6
Impact of the 13-valent pneumococcal vaccine on serotypes and antibiotic susceptibility in children.13价肺炎球菌疫苗对儿童血清型及抗生素敏感性的影响
J Int Med Res. 2025 Apr;53(4):3000605251336064. doi: 10.1177/03000605251336064. Epub 2025 Apr 30.
7
A global epidemic serotype 14 switching to non-vaccine types.全球流行的血清型14正转向非疫苗型。
Microbiol Spectr. 2025 Mar 31;13(5):e0315124. doi: 10.1128/spectrum.03151-24.
8
serotype distribution in low- and middle-income countries of South Asia: Do we need to revisit the pneumococcal vaccine strategy?南亚低收入和中等收入国家的血清型分布：我们是否需要重新审视肺炎球菌疫苗策略？
Hum Vaccin Immunother. 2025 Dec;21(1):2461844. doi: 10.1080/21645515.2025.2461844. Epub 2025 Feb 25.
9
A population-based study on the burden of hospitalized pediatric pneumococcal disease in Taiwan before and after the introduction of 13-valent pneumococcal conjugate vaccine into the childhood immunization program in 2015.一项基于人群的研究，旨在探讨2015年13价肺炎球菌结合疫苗纳入儿童免疫规划前后台湾地区住院儿童肺炎球菌疾病的负担。
BMC Infect Dis. 2025 Feb 5;25(1):176. doi: 10.1186/s12879-024-10379-z.
10
Long-term impact of 10-valent pneumococcal conjugate vaccine among children <5 years, Uganda, 2014-2021.2014 - 2021年乌干达5岁以下儿童中10价肺炎球菌结合疫苗的长期影响
PLOS Glob Public Health. 2025 Jan 6;5(1):e0002980. doi: 10.1371/journal.pgph.0002980. eCollection 2025.
本文引用的文献
1
One cross-sectional investigation revealed that non-vaccine serotypes of Streptococcus pneumoniae could be identified more frequently in elderly Chinese people.一项横断面调查显示，在中国老年人中，更常可鉴定出肺炎链球菌的非疫苗血清型。
Vaccine. 2021 Jun 2;39(24):3304-3309. doi: 10.1016/j.vaccine.2021.02.053. Epub 2021 May 9.
2
Multi-Valent Protein Hybrid Pneumococcal Vaccines: A Strategy for the Next Generation of Vaccines.多价蛋白杂交肺炎球菌疫苗：下一代疫苗的一种策略。
Vaccines (Basel). 2021 Mar 2;9(3):209. doi: 10.3390/vaccines9030209.
3
Clinical characteristics and serotype distribution of invasive pneumococcal disease in pediatric patients from Beijing, China.中国北京地区儿童侵袭性肺炎球菌病的临床特征和血清型分布。
Eur J Clin Microbiol Infect Dis. 2021 Sep;40(9):1833-1842. doi: 10.1007/s10096-021-04238-x. Epub 2021 Mar 31.
4
Evolution, Clinical and Microbiological Characteristics of Invasive Pneumococcal Disease since the Introduction of the Pneumococcal Conjugate Vaccine 13-Valent in Adults over 18 Years Old.13价肺炎球菌结合疫苗引入18岁以上成人后侵袭性肺炎球菌疾病的演变、临床和微生物学特征
Vaccines (Basel). 2021 Jan 27;9(2):93. doi: 10.3390/vaccines9020093.
5
Genomic Characteristics of Invasive Serotype 1 in New Caledonia Prior to the Introduction of PCV13.在引入13价肺炎球菌结合疫苗（PCV13）之前，新喀里多尼亚侵袭性1型血清型的基因组特征
Bioinform Biol Insights. 2020 Sep 29;14:1177932220962106. doi: 10.1177/1177932220962106. eCollection 2020.
6
Safety, Tolerability, and Immunogenicity of a 20-Valent Pneumococcal Conjugate Vaccine (PCV20) in Adults 60 to 64 Years of Age.60 至 64 岁成人中 20 价肺炎球菌结合疫苗（PCV20）的安全性、耐受性和免疫原性。
Clin Infect Dis. 2021 Oct 5;73(7):e1489-e1497. doi: 10.1093/cid/ciaa1045.
7
Whole genome sequencing of macrolide resistant Streptococcus pneumoniae serotype 19A sequence type 416.大环内酯类耐药 19A 血清型肺炎链球菌 416 序列型的全基因组测序。
BMC Microbiol. 2020 Jul 25;20(1):224. doi: 10.1186/s12866-020-01909-1.
8
A New Pneumococcal Capsule Type, 10D, is the 100th Serotype and Has a Large Fragment from an Oral Streptococcus.一种新型肺炎球菌荚膜类型 10D 是第 100 种血清型，具有来自口腔链球菌的大片段。
mBio. 2020 May 19;11(3):e00937-20. doi: 10.1128/mBio.00937-20.
9
Impact of vaccination on invasive pneumococcal disease in Italy 2007-2017: surveillance challenges and epidemiological changes.2007-2017 年意大利疫苗接种对侵袭性肺炎球菌病的影响：监测挑战和流行病学变化。
Epidemiol Infect. 2020 May 18;148:e187. doi: 10.1017/S0950268820001077.
10
Efficacy of a Protein Vaccine and a Conjugate Vaccine Against Co-colonization with Vaccine-type and Non-vaccine Type Pneumococci in Mice.一种蛋白质疫苗和一种结合疫苗对小鼠中疫苗型和非疫苗型肺炎球菌共定植的疗效。
Pathogens. 2020 Apr 10;9(4):278. doi: 10.3390/pathogens9040278.
Zotero 插件